(Q37251758)

19 August 2017

title

Mitochondrial dysfunction and delayed hepatotoxicity: another lesson from troglitazone (English)

1 reference

19 August 2017

1 reference

1 reference

N L Julie

1

1 reference

19 August 2017

I M Julie

series ordinal

2

1 reference

19 August 2017

A I Kende

series ordinal

3

1 reference

19 August 2017

G L Wilson

series ordinal

4

1 reference

19 August 2017

publication date

23 August 2008

1 reference

19 August 2017

1 reference

19 August 2017

volume

51

1 reference

19 August 2017

issue

11

1 reference

19 August 2017

page(s)

2108-2116

1 reference

https://scigraph.springernature.com/pub.10.1007/s00125-008-1133-6

19 August 2017

exact match

0 references

cites work

Effects of alcohol and oxidative stress on liver pathology: the role of the mitochondrion

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00125-008-1133-6

Severe but reversible cholestatic liver injury after pioglitazone therapy

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00125-008-1133-6

Hepatotoxicity development during antiretroviral therapy containing protease inhibitors in patients with HIV: the role of hepatitis B and C virus infection

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00125-008-1133-6

Valproate-induced hepatic injury: analyses of 23 fatal cases

21 January 2018

1 reference

12 December 2020

Acute myopathy in a type 2 diabetic patient on combination therapy with metformin, fenofibrate and rosiglitazone

1 reference

12 December 2020

Troglitazone-induced hepatic necrosis in an animal model of silent genetic mitochondrial abnormalities

1 reference

12 December 2020

Drug-associated mitochondrial toxicity and its detection

1 reference

12 December 2020

Pioglitazone-associated fulminant hepatic failure

1 reference

12 December 2020

Hepatotoxicity during rapid intravenous loading with amiodarone: Description of three cases and review of the literature

1 reference

12 December 2020

Rapid-onset subfulminant liver failure associated with troglitazone

1 reference

12 December 2020

Drug-induced liver injury: mechanisms and test systems.

1 reference

12 December 2020

Severe cholestatic hepatitis caused by thiazolidinediones: risks associated with substituting rosiglitazone for troglitazone

1 reference

12 December 2020

Receptor-independent actions of PPAR thiazolidinedione agonists: is mitochondrial function the key?

1 reference

12 December 2020

Thiazolidinediones, like metformin, inhibit respiratory complex I: a common mechanism contributing to their antidiabetic actions?

1 reference

12 December 2020

Metabolic and non-metabolic factors determining troglitazone hepatotoxicity: a review

1 reference

12 December 2020

Rosiglitazone-induced granulomatous hepatitis

1 reference

12 December 2020

The ins and outs of mitochondrial dysfunction in NASH.

1 reference

12 December 2020

Strategies to reduce late-stage drug attrition due to mitochondrial toxicity

1 reference

12 December 2020

Mitochondrial permeability transition as a potential determinant of hepatotoxicity of antidiabetic thiazolidinediones

1 reference

12 December 2020

Adverse events with concomitant use of simvastatin or atorvastatin and thiazolidinediones

1 reference

12 December 2020

Hepatocellular injury in a patient receiving rosiglitazone. A case report

1 reference

12 December 2020

Mitochondria in steatohepatitis

1 reference

12 December 2020

Severe intrahepatic cholestasis caused by amiodarone toxicity after withdrawal of the drug: a case report and review of the literature

1 reference

12 December 2020

Hydrogen peroxide overproduction in megamitochondria of troglitazone-treated human hepatocytes

1 reference

12 December 2020

Mitochondrial impairment by PPAR agonists and statins identified via immunocaptured OXPHOS complex activities and respiration

1 reference

12 December 2020

Mitochondria, ciglitazone and liver: a neglected interaction in biochemical pharmacology

1 reference

12 December 2020

Mechanisms of troglitazone hepatotoxicity

1 reference

12 December 2020

Identification of a novel mitochondrial protein (“mitoNEET”) cross-linked specifically by a thiazolidinedione photoprobe

1 reference

12 December 2020

Localization of the Wilson's disease protein product to mitochondria

1 reference

12 December 2020

Late-onset troglitazone-induced hepatic dysfunction

1 reference

12 December 2020

Cumulative insults to mitochondrial function may promote the emergence of 'syndrome X' and diabetes mellitus in HIV/HCV co-infected patients

1 reference

12 December 2020

Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it.

1 reference

12 December 2020

Oxidative stress mediated idiosyncratic drug toxicity

1 reference

12 December 2020

Severe hepatotoxicity associated with troglitazone

1 reference

12 December 2020

Thiazolidinedione bioactivation: a comparison of the bioactivation potentials of troglitazone, rosiglitazone, and pioglitazone using stable isotope-labeled analogues and liquid chromatography tandem mass spectrometry

1 reference

12 December 2020

Myositis, microvesicular hepatitis, and progression to cirrhosis from troglitazone added to simvastatin

1 reference

12 December 2020

Mitochondrial hepatopathies

1 reference

12 December 2020

Mitochondrial function: use it or lose it

1 reference

12 December 2020

Troglitazone-associated hepatic failure

1 reference

12 December 2020

Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes

1 reference

12 December 2020

Hepatitis B or hepatitis C virus infection is a risk factor for severe hepatic cytolysis after initiation of a protease inhibitor-containing antiretroviral regimen in human immunodeficiency virus-infected patients. The APROCO Study Group

1 reference

12 December 2020

In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease

1 reference

12 December 2020

Fatal hepatic failure due to prolonged amiodarone treatment.

1 reference

12 December 2020

Steatohepatitis-inducing drugs cause mitochondrial dysfunction and lipid peroxidation in rat hepatocytes

1 reference

12 December 2020

Ethanol stimulates the production of reactive oxygen species at mitochondrial complexes I and III.

1 reference

12 December 2020

Hepatitis B and C virus co-infection and the risk for hepatotoxicity of highly active antiretroviral therapy in HIV-1 infection

1 reference

12 December 2020

Troglitazone-induced fulminant hepatitis: report of a case with autopsy findings

1 reference

12 December 2020

Thiazolidinedione toxicity to isolated hepatocytes revealed by coherent multiprobe fluorescence microscopy and correlated with multiparameter flow cytometry of peripheral leukocytes

1 reference

12 December 2020

Low dose amiodarone causing pseudo-alcoholic cirrhosis

1 reference

12 December 2020

Two cases of severe clinical and histologic hepatotoxicity associated with troglitazone

1 reference

12 December 2020

Methyldopa liver damage.

1 reference

12 December 2020

Mechanisms of hepatic transport of drugs: implications for cholestatic drug reactions

1 reference

12 December 2020

Gastrointestinal manifestations of mitochondrial disease

1 reference

12 December 2020

Diabetic KKAy mice exhibit increased hepatic PPARgamma1 gene expression and develop hepatic steatosis upon chronic treatment with antidiabetic thiazolidinediones

1 reference

12 December 2020

Pioglitazone-induced hepatic injury in a patient previously receiving troglitazone with success

1 reference

12 December 2020

Animal models of human disease in drug safety assessment

1 reference

12 December 2020

POLG mutations associated with Alpers' syndrome and mitochondrial DNA depletion

1 reference

12 December 2020

Cholestatic potential of troglitazone as a possible factor contributing to troglitazone-induced hepatotoxicity: in vivo and in vitro interaction at the canalicular bile salt export pump (Bsep) in the rat.

1 reference

12 December 2020

Histopathologic changes associated with fialuridine hepatotoxicity

1 reference

12 December 2020

Suspected drug-induced liver fatalities reported to the WHO database

1 reference

12 December 2020

10.1007/S00125-008-1133-6

Identifiers

DOI

1 reference

19 August 2017

1 reference